Xin Cai

Discovery of Novel 1-Cyclopentenyl-3-phenylureas as Selective, Brain Penetrant, and Orally Bioavailable CXCR2 Antagonists.

Wei Zhang, Xichen Lin, R. Copley, 2018, Journal of medicinal chemistry.

Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders.

J. D. Elliott, Wei Zhang, Yan Xu, 2016, ACS medicinal chemistry letters.

2-Aminopyrimidin-4(1H)-one as the novel bioisostere of urea: discovery of novel and potent CXCR2 antagonists.

J. D. Elliott, Wei Zhang, Xichen Lin, 2014, Bioorganic & medicinal chemistry letters.

The Relationship Among Intestinal Bacteria, Vitamin K and Response of Vitamin K Antagonist: A Review of Evidence and Potential Mechanism

Wei Zhang, Fan Luo, Weihua Huang, 2022, Frontiers in Medicine.

Novel complex crystal structure of prolyl hydroxylase domain-containing protein 2 (PHD2): 2,8-Diazaspiro[4.5]decan-1-ones as potent, orally bioavailable PHD2 inhibitors.

J. D. Elliott, Wei Zhang, Xichen Lin, 2013, Bioorganic & medicinal chemistry.

Systematic Mendelian randomization study of the effect of gut microbiome and plasma metabolome on severe COVID-19

Wei Zhang, Han Yan, Pan Xie, 2023, Frontiers in immunology.